Hetero Healthcare Ltd Launches Hetran- A New Era in Acid Blocker Therapy MD Brand Connect5 July 2024 11:30 AM ISTUnderstanding the growing need for effective gastric acid related diseases treatment, Hetero Healthcare Ltd, one of India's leading generic...
Hetero Healthcare Ltd Introduces Hetran, Pioneering a New Generation of Acid Blockers MD Brand Connect27 Jun 2024 12:20 PM ISTHetero Healthcare Ltd, one of India's leading pharmaceutical companies, has launched Vonoprazan, a new-age acid blocker, under the brand name Hetran....
On-demand vonoprazan reasonable alternative to daily therapy for non erosive reflux disease Dr Riya Dave9 Dec 2023 1:15 AM ISTA recent study evaluating the efficacy of on-demand vonoprazan in managing heartburn has shown promising results. The research, led by Dr. Ronnie Fass...
Potassium-Competitive Acid Blockers (P- CABs) for GERD Management - Potential Game Changer or Washout? Dr Jeegar Dattani7 Dec 2023 11:30 AM ISTProton pump Inhibitors have been used globally for the management of gastroesophageal disease (GERD) and Acid Peptic Disease (APD) for a long time....
BDR Pharma Gets CDSCO Panel Nod To Study Vonoprazan Tablets Dr. Divya Colin15 Nov 2023 6:30 PM ISTNew Delhi: The drug major BDR Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
FDA approves vonoprazan for all grades of erosive GERD Dr. Kamal Kant Kohli4 Nov 2023 11:15 AM ISTThe US Food and Drug Administration has approved a first-in-class oral potassium-competitive acid blocker vonoprazan (Voquezna) for all grades of...
Dr. Reddy's Gets CDSCO Panel Nod to study gastric acid blocker Vonoprazan fumarate Dr. Divya Colin1 Jun 2023 6:00 PM ISTNew Delhi: In line with the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Vonoprazan effective against Clostridoides difficile infection: Study Jacinthlyn Sylvia16 March 2023 9:15 AM ISTVonoprazan as safe and effective as proton pump inhibitors (PPIs) against Clostridioides difficile infection (CDI) suggests an article published in...
Vonoprazan significantly lowers heartburn symptoms in nonerosive GERD Dr. Kamal Kant Kohli12 Jan 2023 8:00 PM ISTAccording to topline results from a phase 3 four-week, double-blind, placebo-controlled trial, Vonoprazan was associated with a significantly...
Vonoprazan as effective as Lansoprazole in treating Severe Erosive Esophagitis: AGA Jacinthlyn Sylvia14 Oct 2022 7:30 PM ISTIn a new study conducted by Loren Laine and team it was found that in the treatment and maintenance of the recovery from erosive esophagitis,...
Vonoprazan-based triple and dual regimens effective for treatment of H.pylori infection Dr. Hiral patel17 Jun 2022 6:00 AM ISTUSA: Vonoprazan triple therapy and dual therapy, both regimens were superior to PPI-based triple therapy in clarithromycin-resistant strains and in...
C difficile infection risk not raised with vonoprazan, when compared to PPIs: Study Dr Satabdi Saha9 Jun 2021 9:00 AM ISTIn a recent study, researchers have found a significant positive association between vonoprazan use and Clostridioides difficile infection (CDI) ;...
